Lebrillenc By Beaute de Paris Takes Age Spots and Years off Women's Faces
Lebrillenc helps women look young again by diminishing their age spots

November 15, 2011 /24-7PressRelease/ -- Age spots are a telltale sign of - well - age. Those brown, circular marks that dot the face bespeak many years gone by, and every bearer is acutely aware of their close association with the elderly. Even a wrinkle-free face looks aged with these marks. So it almost goes without saying that the opportunity to rid these spots would be a prized one indeed. That opportunity is Lebrillenc Beaute de Paris' skin brighter cream that lightens any and all facial blemishes. After using Lebrillenc skin is visibly smoother and more even, and age spots are dramatically reduced.

AMA laboratories put Lebrillenc to the test found that after just four weeks of use, skin tone was lightened and brightened up to 55%, and after eight weeks of use, age spots were reduced by up to 77%. Lebrillenc even diminishes the appearance of freckles.

Lebrillenc uses alpha-hydroxy acids to exfoliate away dead, dull, blemished skin cells and reveal the fresh skin that lies beneath. It is designed to execute this process gently, as its manufacturers are mindful of sensitive skin; Lebrillenc age spot treatment is non-irritating and 100% hydroquinone-free.

To view purchase options and read more about Lebrillenc visit www.beautedeparis.fr. Ordering can also be done through this toll-free number: 1(888) 566-5642. A single bottle is $99.99.Two bottles are $129.99, plus FREE shipping.

About Beaute de Paris
Beaute de Paris is a French beauty products company that caters to both men and women. It currently offers products that reduce wrinkles, stimulate eyelash growth, promote thicker eyebrows, improve skin brightening and diminish eye bags and dark circles. Beaut? de Paris products are manufactured with great precision and are tested by independent laboratories.

CONTACT:
Rich Fuchs
rich@lab88.com
888.look.nice
888.566.5642 Ext. 106

Press Release Contact Information:

EIN News